L-arginine destabilizes oral multi-species biofilm communities developed in human saliva

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Kolderman, Ethan ^a   Bettampadi, Deepti ^a   Samarian, Derek ^a   Dowd, Scot E ^b   Foxman, Betsy ^a   Jakubovics, Nicholas S ^c   Rickard, Alexander H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Molecular Research LP MR DNA   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CETYLPYRIDINIUM SALT; ANTIINFECTIVE AGENT;

AGGREGATIBACTER; ANALYTICAL EQUIPMENT; ANALYTICAL PARAMETERS; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; BIOVOLUME; CELL INTERACTION; COMMUNITY STRUCTURE; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED FLOW MICROFLUIDIC SYSTEM; CONTROLLED STUDY; DRUG PENETRATION; HUMAN; NEISSERIA; NONHUMAN; PH; POPULATION ABUNDANCE; SALIVA; STATIC MICROPLATE SYSTEM; STREPTOCOCCUS; VEILLONELLA; DRUG EFFECTS; MICROBIOLOGY; MICROFLORA;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; NEISSERIA; STREPTOCOCCUS; VEILLONELLA;

ANTI-BACTERIAL AGENTS; ARGININE; BIOFILMS; HUMANS; MICROBIOTA; SALIVA;

EID: 84929190785     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121835     Document Type: Article

References (63)

1. Marsh PD. Dental plaque as a microbial biofilm. Caries Res. 2004; 38: 204-211. PMID: 15153690
2. Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J Dent Res. 2009; 88: 982-990. doi: 10.1177/0022034509346811 PMID: 19828884
3. Marsh PD. Controlling the oral biofilm with antimicrobials. J Dent. 2010; 38 Suppl 1: S11-15. doi: 10. 1016/S0300-5712(10)70005-1 PMID: 20621238
4. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol. 2002; 46: 202-256. PMID: 12073654
5. Kolenbrander PE, Palmer RJ Jr., Rickard AH, Jakubovics NS, Chalmers NI, Diaz PI. Bacterial interactions and successions during plaque development. Periodontol 2000. 2006; 42: 47-79. PMID: 16930306
6. Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmür R, et al. Oral biofilm architecture on natural teeth. PloS One. 2010; 5: e9321. doi: 10.1371/journal.pone.0009321 PMID: 20195365
7. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001; 9: 34-39. PMID: 11166241
8. ten Cate JM, Zaura E. The numerous microbial species in oral biofilms: how could antibacterial therapy be effective? Adv Dent Res. 2012; 24: 108-111. doi: 10.1177/0022034512450028 PMID: 22899691
9. Anon. Oral health: Preventing cavities, gum disease, tooth loss, and oral cancers. CDC. 2011; Available: http://www.cdc.gov/chronicdisease/resources/publications/aag/doh.htm.
10. Roberts AP, Mullany P. Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance. Expert Rev Anti Infect Ther. 2010; 8: 1441-1450. doi: 10.1586/eri.10.106 PMID: 21133668
11. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol. 2005; 99: 703-715. PMID: 16162221
12. Marsh PD. Plaque as a biofilm: pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis. 2003; 9 Suppl 1: 16-22. PMID: 12974526
13. Allaker RP, Douglas CW. Novel anti-microbial therapies for dental plaque-related diseases. Int J Antimicrob Agents. 2009; 33: 8-13. doi: 10.1016/j.ijantimicag.2008.07.014 PMID: 18804350
14. Kasper SH, Samarian D, Jadhav AP, Rickard AH, Musah RA, Cady NC. S-Aryl-l-cysteine sulphoxides and related organosulphur compounds alter oral biofilm development and AI-2-based cell-cell communication. J Appl Microbiol. 2014; 117:1472-1486. doi: 10.1111/jam.12616 PMID: 25081571
15. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res. 2007; 86: 618-622. PMID: 17586707
16. Jakubovics NS, Shields RC, Rajarajan N, Burgess JG. Life after death: the critical role of extracellular DNA in microbial biofilms. Lett Appl Microbiol. 2013; 57: 467-475. doi: 10.1111/lam.12134 PMID: 23848166
17. Wu CC, Lin CT, Wu CY, Peng WS, Lee MJ, Tsai YV. Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation. Mol Oral Microbiol. 2015; 30: 16-26. doi: 10.1111/omi.12063 PMID: 24961744
18. Nascimento MM, Browngardt C, Xiaohui X, Klepac-Ceraj V, Paster BJ, Burne RA. The effect of arginine on oral biofilm communities. Mol Oral Microbiol. 2014; 29: 45-54. doi: 10.1111/omi.12044 PMID: 24289808
19. Nascimento MM, Liu Y, Kalra R, Perry S, Adewumi A, Xu X, et al. Oral arginine metabolism may decrease the risk for dental caries in children. J Dent Res. 2013; 92: 604-608. doi: 10.1177/ 0022034513487907 PMID: 23640952
20. Rogers AH, Zilm PS, Gully NJ. Influence of arginine on the coexistence of Streptococcus mutans and S. milleri in glucose-limited mixed continuous culture. Microb Ecol. 1987; 14: 193-202. doi: 10.1007/ BF02012940 PMID: 24202714
21. Sharma S, Lavender S, Woo J, Guo L, Shi W, Kilpatrick-Liverman L, et al. Nanoscale characterization of effect of L-arginine on Streptococcus mutans biofilm adhesion by atomic force microscopy. Microbiology. 2014; 160: 1466-1473. doi: 10.1099/mic.0.075267-0 PMID: 24763427
22. Gordan VV, Garvan CW, Ottenga ME, Schulte R, Harris PA, McEdward D, et al. Could alkali production be considered an approach for caries control? Caries Res. 2010; 44: 547-554. doi: 10.1159/ 000321139 PMID: 21071940
23. Nascimento MM, Gordan VV, Garvan CW, Browngardt CM, Burne RA. Correlations of oral bacterial arginine and urea catabolism with caries experience. Oral Microbiol Immunol. 2009; 24: 89-95. doi: 10. 1111/j.1399-302X.2008.00477.x PMID: 19239634
24. Jakubovics NS, Gill SR, Iobst SE, Vickerman MM, Kolenbrander PE. Regulation of gene expression in a mixed-genus community: stabilized arginine biosynthesis in Streptococcus gordonii by coaggregation with Actinomyces naeslundii. J Bacteriol. 2008; 190: 3646-3657. doi: 10.1128/JB.00088-08 PMID: 18359813
25. Xie H, Lin X, Wang BY, Wu J, Lamont RJ. Identification of a signalling molecule involved in bacterial intergeneric communication. Microbiology. 2007; 153: 3228-3234. PMID: 17906122
26. Kamaguch A, Nakayama K, Ohyama T, Watanabe T, Okamoto M, Baba H. Coaggregation of Porphyromonas gingivalis and Prevotella intermedia. Microbiol Immunol. 2001; 45: 649-656. PMID: 11694077
27. Ellen RP, Song M, Buivids IA. Inhibition of Actinomyces viscosus-Porphyromonas gingivalis coadhesion by trypsin and other proteins. Oral Microbiol Immunol. 1992; 7: 198-203. PMID: 1328996
28. Wong L, Sissons C. A comparison of human dental plaque microcosm biofilms grown in an undefined medium and a chemically defined artificial saliva. Arch Oral Biol. 2001; 46: 477-486. PMID: 11311195
29. Sissons CH. Artificial dental plaque biofilm model systems. Adv Dent Res. 1997; 11: 110-126. PMID: 9524448
30. Pratten J, Wills K, Barnett P, Wilson M. In vitro studies of the effect of antiseptic-containing mouthwashes on the formation and viability of Streptococcus sanguis biofilms. J Appl Microbiol. 1998; 84: 1149-1155. PMID: 9717301
31. Bjorklund M, Ouwehand AC, Forssten SD. Improved artificial saliva for studying the cariogenic effect of carbohydrates. Curr Microbiol. 2011; 63: 46-49. doi: 10.1007/s00284-011-9937-x PMID: 21533590
32. Shelburne SA 3rd, Granville C, Tokuyama M, Sitkiewicz I, Patel P, Musser JM. Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect Immun. 2005; 73: 4723-4731. PMID: 16040985
33. De Jong MH, Van der Hoeven JS. The growth of oral bacteria on saliva. J Dent Res. 1987; 66: 498-505. PMID: 3305628
34. Nance WC, Dowd SE, Samarian D, Chludzinski J, Delli J, Battista J, et al. A high-throughput microfluidic dental plaque biofilm system to visualize and quantify the effect of antimicrobials. J Antimicrob Chemother. 2013; 68: 2550-2560. doi: 10.1093/jac/dkt211 PMID: 23800904
35. Fu D, Pei D, Huang C, Liu Y, Du X, Sun H. Effect of desensitising paste containing 8% arginine and calcium carbonate on biofilm formation of Streptococcus mutans in vitro. J Dent. 2013; 41: 619-627. doi: 10.1016/j.jdent.2013.04.013 PMID: 23643848
36. Gilbert P, Allison DG, McBain AJ. Biofilms in vitro and in vivo: do singular mechanisms imply crossresistance?J Appl Microbiol. 2002; 92 Suppl: 98S-110S. PMID: 12000619
37. Ishak HD, Plowes R, Sen R, Kellner K, Meyer E, Estrada DA, et al. Bacterial diversity in Solenopsis invicta and Solenopsis geminata ant colonies characterized by 16S amplicon 454 pyrosequencing. Microb Ecol. 2011; 61: 821-831. doi: 10.1007/s00248-010-9793-4 PMID: 21243351
38. Callaway TR, Dowd SE, Edrington TS, Anderson RC, Krueger N, Bauer N, et al. Evaluation of the bacterial diversity in the rumen and feces of cattle fed diets containing different levels of dried distiller's grains plus solubles using bacterial tag-encoded FLX amplicon pyrosequencing. J Anim Sci. 2010; 88: 3977-3983. doi: 10.2527/jas.2010-2900 PMID: 20729286
39. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersbøll BK, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology. 2000; 146: 2395-2407. PMID: 11021916
40. Collins TJ. ImageJ for microscopy. Biotechniques. 2007; 43: 25-30. PMID: 17936939
41. Solomons CC, Cotton EK, Dubois R. The use of buffered L-arginine in the treatment of cystic fibrosis. Pediatrics. 1971; 47: 384-390. PMID: 5100777
42. Borriello G, Richards L, Ehrlich GD, Stewart PS. Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother. 2006; 50: 382-384. PMID: 16377718
43. Jakubovics NS, Gill SR, Vickerman MM, Kolenbrander PE. Role of hydrogen peroxide in competition and cooperation between Streptococcus gordonii and Actinomyces naeslundii. FEMS Microbiol Ecol. 2008; 66: 637-644. doi: 10.1111/j.1574-6941.2008.00585.x PMID: 18785881
44. Burne RA, Zeng L, Ahn SJ, Palmer SR, Liu Y, Lefebure T, et al. Progress dissecting the oral microbiome in caries and health. Adv Dent Res. 2012; 24: 77-80. doi: 10.1177/0022034512449462 PMID: 22899685
45. Whittaker CJ, Klier CM, Kolenbrander PE. Mechanisms of adhesion by oral bacteria. Annu Rev Microbiol. 1996; 50: 513-552. PMID: 8905090
46. Sato T, Nakazawa F. Coaggregation between Prevotella oris and Porphyromonas gingivalis. J Microbiol Immunol Infect. 2014; 47: 182-186. doi: 10.1016/j.jmii.2012.09.005 PMID: 23245806
47. Grenier D. Demonstration of a bimodal coaggregation reaction between Porphyromonas gingivalis and Treponema denticola. Oral Microbiol Immunol. 1992; 7: 280-284. PMID: 1337373
48. Nagata H, Murakami Y, Inoshita E, Shizukuishi S, Tsunemitsu A. Inhibitory effect of human plasma and saliva on co-aggregation between Bacteroides gingivalis and Streptococcus mitis. J Dent Res. 1990; 69: 1476-1479. PMID: 2384623
49. Levesque C, Lamothe J, Frenette M. Coaggregation of Streptococcus salivarius with periodontopathogens: evidence for involvement of fimbriae in the interaction with Prevotella intermedia. Oral Microbiol Immunol. 2003; 18: 333-337. PMID: 12930529
50. Korber DR, Choi A, Wolfaardt GM, Caldwell DE. Bacterial plasmolysis as a physical indicator of viability. Appl Environ Microbiol. 1996; 62: 3939-3947. PMID: 8899980
51. Evans DJ, Allison DG, Brown MR, Gilbert P. Effect of growth-rate on resistance of gram-negative biofilms to cetrimide. J Antimicrob Chemother. 1990; 26: 473-478. PMID: 2254220
52. Elias Boneta AR, Galan Salas RM, Mateo LR, Stewart B, Mello S, Arvanitidou LS, et al. Efficacy of a mouthwash containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride compared to a commercial mouthwash containing 2.4% potassium nitrate and 0.022% sodium fluoride and a control mouthwash containing 0.05% sodium fluoride on dentine hypersensitivity: a six-week randomized clinical study. J Dent. 2013; 41 Suppl 1: S34-41. doi: 10.1016/j.jdent.2012.11.004 PMID: 23380074
53. Petrou I, Heu R, Stranick M, Lavender S, Zaidel L, Cummins D et al. A breakthrough therapy for dentin hypersensitivity: how dental products containing 8%arginine and calcium carbonate work to deliver effective relief of sensitive teeth. J Clin Dent. 2009; 20: 23-31. PMID: 19489189
54. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43: 5721-5732. PMID: 16272510
55. Ritz HL. Fluorescent antibody staining of Neisseria, Streptococcus and Veillonella in frozen sections of human dental plaque. Arch Oral Biol. 1969; 14: 1073-1083. PMID: 4899757
56. Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, Mongodin EF, et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J. 2010; 4: 962-974. doi: 10.1038/ismej.2010.30 PMID: 20336157
57. Ritz HL. Microbial population shifts in developing human dental plaque. Arch Oral Biol. 1967; 12: 1561-1568. PMID: 5237337
58. Jakubovics NS, Yassin SA, Rickard AH. Community interactions of oral streptococci. Adv Appl Microbiol. 2014; 87: 43-110. doi: 10.1016/B978-0-12-800261-2.00002-5 PMID: 24581389
59. Takemoto T, Ozaki M, Shirakawa M, Hino T, Okamoto H. Purification of arginine-sensitive hemagglutinin from Fusobacterium nucleatum and its role in coaggregation. J Periodontal Res. 1993; 28: 21-26. PMID: 8426279
60. Edwards AM, Grossman TJ, Rudney JD. Association of a high-molecular weight arginine-binding protein of Fusobacterium nucleatum ATCC 10953 with adhesion to secretory immunoglobulin A and coaggregation with Streptococcus cristatus. Oral Microbiol Immunol. 2007; 22: 217-224. PMID: 17600532
61. Kolenbrander PE, Parrish KD, Andersen RN, Greenberg EP. Intergeneric coaggregation of oral Treponema spp. with Fusobacterium spp. and intrageneric coaggregation among Fusobacterium spp. Infect Immun. 1995; 63: 4584-4588. PMID: 7591109
62. Kolenbrander PE, Andersen RN, Moore LV. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect Immun. 1989; 57: 3194-3203. PMID: 2777378
63. Cisar JO, Kolenbrander PE, McIntire FC. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Infect Immun. 1979; 24: 742-752. PMID: 468376